undefined
EUTM file information

018633217

KRAZELVI

January 3, 2022

Trademark Summary

The trademark application KRAZELVI was filed by Mirati Therapeutics, Inc.,, a U.S. corporation (the "Applicant"). The application was published for oppositions on January 27, 2022, and it was registered by office on May 6, 2022 without any oppositions.

The application was filed in English (French was selected as the second language).

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals
    2. Pharmaceutical preparations
    3. Pharmaceutical products
    4. Pharmaceutical preparations for the treatment of cancer
    5. Pharmaceutical preparations for use in oncology
    6. Pharmaceutical preparations for the treatment of infectious diseases
    7. Pharmaceutical preparations for the treatment of lung cancer
    8. Pharmaceutical preparations for the treatment of non-small cell lung carcinoma
    9. Pharmaceutical preparations for the treatment of colorectal carcinoma
    10. Pharmaceutical preparations for the treatment of pancreatic cancer
    11. Pharmaceuticals comprising small molecules
    12. Pharmaceuticals comprising small molecules for the treatment of cancer
    13. Pharmaceuticals comprising small molecules for the treatment of infectious diseases
    14. Pharmaceuticals comprising small molecules for the treatment of lung cancer
    15. Pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma
    16. Pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma
    17. Pharmaceuticals comprising small molecules for the treatment of pancreatic cancer
    18. Pharmaceuticals comprising compounds
    19. Pharmaceuticals comprising compounds for the treatment of cancer
    20. Pharmaceuticals comprising inhibitors
    21. Pharmaceuticals comprising inhibitors for the treatment of cancer
    22. Pharmaceuticals for the treatment of solid tumors
    23. Pharmaceuticals for the treatment of advanced solid tumors.
  • The mark was filed in class 42 with following description of goods:
    1. Research and development of pharmaceuticals in the field of oncology
    2. Providing information in the field of scientific and medical research related to oncology
    3. Research and development of pharmaceuticals
    4. Providing information in the field of scientific and medical research related to pharmaceuticals.